N
Google TrendMATTHEW STONE SR (200+) — Adult victims, suspected shooter ID'd in Erie mass shooting
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:matthew stone sr200+selma blair2000+al-nassr vs neftchi fergana5000+samantha busch500+crimson rescued mountain lion cub500+peggy flanagan200+sean combs10000+boeing 747500+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "ctDNA Testing May Help Mo" (30 stories)

Top Headline Story

Tumor DNA May Help Guide Treatment for MIBC Surgery and Bladder-Sparing Therapy
Lead StoryRenal and Urology Newsgeneral
Mar 19

Tumor DNA May Help Guide Treatment for MIBC Surgery and Bladder-Sparing Therapy

<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxOTHpyUkJQS2dHZk1yclNRRl8tTVIxaEVGTGsxLXZPd0oxcF93VUpQdjRqZVFKRkRjYmt4TWJJLTM3SXczVDFHa1kwZHBRN20xdF9CbkpBWWctcDFBWnZDTkhNQ1pnaDhIcnJIY2l0enhqSy1OVU9hMk1nbkpjMVA4czFFYUFTUV9OdGVKSVVudVdET0hXVzdB?oc=5" target="_blank">Tumor DNA May Help Guide Treatment for MIBC Surgery and Bladder-Sparing Therapy</a>  <font color="#6f6f6f">Renal and Urology News</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
200+19m ago

matthew stone sr

Adult victims, suspected shooter ID'd in Erie mass shooting

Filter stories
2000+39m ago

selma blair

Selma Blair arrested for biting flight attendant, trying to open plane door

Filter stories
5000+49m ago

al-nassr vs neftchi fergana

Al Nassr Asian Champions League clash in doubt over Riyadh security situation

Filter stories
500+49m ago

samantha busch

Kyle Busch’s Widow Samantha Calls His Death ‘Unfair’ After ‘Emotional’ Celebration for Beloved NASCAR Star

Filter stories

Search Results for "ctDNA Testing May Help Mo"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Does ctDNA-Guided Surveillance After Curative-Intent Surgery Benefit Outcomes in Cases of Recurrent Colorectal Cancer
The ASCO Postgeneral

Does ctDNA-Guided Surveillance After Curative-Intent Surgery Benefit Outcomes in Cases of Recurrent Colorectal Cancer

<a href="https://news.google.com/rss/articles/CBMi7AFBVV95cUxQSnY3OFpNdFdDWU55XzJmMUxDX2UyT3RZbkFBLUQyWkhnQlExby1GM1phN0V2N0RCUWZtb2lqYXlKeUpSdllPd3lLb1VzWHJMXzBoNnB0VUhhekozVnExZmVtY18tYTZmblotbUdudUt4WG5XQUFtNk1FMzNKRkhTRjNXel85ZDFLQVYxbGlYQ2QtNnZIaUxBckJhNnd3VGlCT0JOc1VLR3dFTW1FYUp4al8zTU82TEthMjZpbjMxbndqNDZhd2pnUWVtaTM3UXBNRF9RdTRJRE5QZW9lR190RmlUUFZnZnZXZGRKMQ?oc=5" target="_blank">Does ctDNA-Guided Surveillance After Curative-Intent Surgery Benefit Outcomes in Cases of Recurrent Colorectal Cancer</a>  <font color="#6f6f6f">The ASCO Post</font>

Read Full StoryMore like this
From detection to action: ctDNA-MRD surveillance and translational strategies in early breast cancer
Frontiersgeneral

From detection to action: ctDNA-MRD surveillance and translational strategies in early breast cancer

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxQbjZKTDk0YVhWWWJFbjAzZWdWNTJsY2wzdm1VXy1qZnJ3RUZLNEp0T1NPTHhYQlhkVFdtY0FCY2xYUjNQaEJFbndLbERZb0NsU1l0S3FtaEFTb19KLUNiZ0xyMkREX0R5d1VtTUg5RlU5T19pRFpoNzF2ZExyWmNpOWZydHF5NFFNV3phdld3?oc=5" target="_blank">From detection to action: ctDNA-MRD surveillance and translational strategies in early breast cancer</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
BCANTT 2026: Operationalizing ctDNA in Bladder Cancer Clinical Trials
UroTodaygeneral

BCANTT 2026: Operationalizing ctDNA in Bladder Cancer Clinical Trials

<a href="https://news.google.com/rss/articles/CBMi2AFBVV95cUxOd1NRVFZPT3ZJZExab2tjUG9lMEdFOVVkVi1YdU9xczYyMEJLNUlGLUpkVUNrRDRMMl93RzRza2hLX3pJY2QzaFA0UkRDLW9tR2M5MkJRbEhCUmFxeGJYYTdOMVNxQm0wLXQtU0dCeF9HcThvMnZGRm1QR3FqR2hNVllib2cxd1NFcWI4UmFGMUVzUW82SUhGZGNKajhHNklaRW1GNVc5Wk1wb2dmSVpoVWdKd0NSU1d2SEhvVWp1bjY5UXZLemM3eFpwOUdyOUhfaHc0VkphOFU?oc=5" target="_blank">BCANTT 2026: Operationalizing ctDNA in Bladder Cancer Clinical Trials</a>  <font color="#6f6f6f">UroToday</font>

Read Full StoryMore like this
Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancer
Naturegeneral

Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancer

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9sZHBjaGw4NVl4Wmk1NFFaZ0g0b05IaDAtZkZtRzFkdlNhaXZrQ3dGM0x3ZVcwVDRxUXlCX2RRVXlxd3JkbGZ3dXpMZHR2cmpNSVFuRXUzWXVUZjh6MDE4?oc=5" target="_blank">Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancer</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Preop ctDNA May Identify Aggressive Bladder Cancer Better Than Nodal Status
Renal and Urology Newsgeneral

Preop ctDNA May Identify Aggressive Bladder Cancer Better Than Nodal Status

<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxOMWVONHlMWnlDN3NTTGZtRko0dXJGOXVBZTNzakVHQ1ZtMDhLTUFnemVmWkpWSDFjcnp5X2JsUWlMbzR4UHVoR1RxSVRiMDI0R1JROTZEenpqZDFKTjJ5UTMwRnJSUzlZblVOal8zNUlDS1BwZGhnbWZSci0zMHpqOUJGX3dDMzlENW9ITDhaanVLX1Z5bXhjZHFtRW91SGVGV3lQXy0xSVdTeVE?oc=5" target="_blank">Preop ctDNA May Identify Aggressive Bladder Cancer Better Than Nodal Status</a>  <font color="#6f6f6f">Renal and Urology News</font>

Read Full StoryMore like this
Implementation of a 1021-gene liquid biopsy assay for real-world tumor genomic profiling in oncology practice
Natureworld

Implementation of a 1021-gene liquid biopsy assay for real-world tumor genomic profiling in oncology practice

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBEenlZWmpybmlNT2tPVXN5MlJiRXhwUksxYjFGRGNtVjFQMGp2M25DVEt1MzRnaHJpSWRad29GdFdHUnc2Z0lsWkRfY0QzLUlZeXo3SUJRR09US1RYZEw0?oc=5" target="_blank">Implementation of a 1021-gene liquid biopsy assay for real-world tumor genomic profiling in oncology practice</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Catching Cancer Recurrence with Circulating Tumor DNA (ctDNA) Tests: 5 Things to Know
Fox Chase Cancer Centergeneral

Catching Cancer Recurrence with Circulating Tumor DNA (ctDNA) Tests: 5 Things to Know

<a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxNS2dMRlN6SzZFV1Rld0NVVXpJUXR3ODdHUkl5RUFqVG1GOFhCN0NQWmRWczA3bmx1b0dYOE82enN0ZlJhQ0tRWFJtVm9PV1JiUlpSOTU1WnhITzkyWTg3c1dET0dFcmttdGhwWUlCWUJIR0NMNTVrUmZGdGtPUkFmdnBwYw?oc=5" target="_blank">Catching Cancer Recurrence with Circulating Tumor DNA (ctDNA) Tests: 5 Things to Know</a>  <font color="#6f6f6f">Fox Chase Cancer Center</font>

Read Full StoryMore like this
Evolving Role of Circulating Tumor DNA in Gastrointestinal Malignancies
ASCO Daily Newsgeneral

Evolving Role of Circulating Tumor DNA in Gastrointestinal Malignancies

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxPRzR5dnQzTGJ6ellKZ0JRM1VSSGFydWV5RnRnNlZIRnAxX1Fiak9udGQyTnFDNFR4OWVHV0M1R0UyVEV4SWNzUFlMd0FsQngwVTUyMFZYTFZOWmtpRXlueldFUkJYa1R3c2Z0RzlpYjRyQlp0RlFSaEtOVGM4cWxTM3RxaXZwUnF1VVhMT0tZelFHTzNDaVRRU0hEVkZPeWVu?oc=5" target="_blank">Evolving Role of Circulating Tumor DNA in Gastrointestinal Malignancies</a>  <font color="#6f6f6f">ASCO Daily News</font>

Read Full StoryMore like this
Early ctDNA Testing Provides Another Tool for Predicting Survival Outcomes With Tebentafusp in Metastatic Uveal Melanoma
OncLivegeneral

Early ctDNA Testing Provides Another Tool for Predicting Survival Outcomes With Tebentafusp in Metastatic Uveal Melanoma

<a href="https://news.google.com/rss/articles/CBMi4wFBVV95cUxOTUdhY1l5TXRPRE1JdDV0LVk2R2g1UjZabXRORm9ia25XQ3VPREk5MkhFRGNXVG1FeDhveE13OC1OOHhYYWMxcmJ6cmhPVWJkZFVlbXU3Sk9NVUpheFQ1Nmt5dng3czdKX2s3cXNWbnpnTGFYMlAxdWtZMmtXdlV2WFdwamthU0VyS0Z3b3lhQVFoeFhnWEl1RlBOQXlvbng4enp1d1FOWlNYZjRFUHUtRVhUVXQxcG1xQTFqZTF5N21fN3k2NnA0bEpoUWxZUlZEWDlYUi1NSFd2cm41UW9XdnY3NA?oc=5" target="_blank">Early ctDNA Testing Provides Another Tool for Predicting Survival Outcomes With Tebentafusp in Metastatic Uveal Melanoma</a>  <font color="#6f6f6f">OncLive</font>

Read Full StoryMore like this
ctDNA Testing in Colorectal Cancer Deemed Promising but Not Ready for Prime Time
Cancer Therapy Advisorgeneral

ctDNA Testing in Colorectal Cancer Deemed Promising but Not Ready for Prime Time

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxPTXZFWjBOT3VaeUtsdFFYVU83NXlQRjlzMVp3d2JFMjEwSVp1RmlaNGJoU19sWTRmSXhULTByX051VzJiWkwzUDZMVE1DUlBHdHd6RlY3TWs4U2ZXTDVqUk1RU1NBNW9DM1ZKQ0FKZ05QcUpPNHB6Sm9LRkh2OHRIN015bzd1MGszOXZ3Y2ZUVTZMaUh3dzY5QURzTW5USEtmYnpvdmxGYWdzQ2xFbUZHZFh5clBVZw?oc=5" target="_blank">ctDNA Testing in Colorectal Cancer Deemed Promising but Not Ready for Prime Time</a>  <font color="#6f6f6f">Cancer Therapy Advisor</font>

Read Full StoryMore like this
Liquid Biopsy and Imaging Are Complementary for Assessing Tumor Burden
RSNA Journalsgeneral

Liquid Biopsy and Imaging Are Complementary for Assessing Tumor Burden

<a href="https://news.google.com/rss/articles/CBMiW0FVX3lxTFBYU3VidnBxVkJQb0k5cGlvbEc1TF9VX1BESlpMTmZfSTd4NTRfdWNSUi11RjAzS0NHRU1ndXA2a3Z4N1UzQm5zaVhhUENneVJBNVh3cTBJTVdHMTQ?oc=5" target="_blank">Liquid Biopsy and Imaging Are Complementary for Assessing Tumor Burden</a>  <font color="#6f6f6f">RSNA Journals</font>

Read Full StoryMore like this
Clinical application of liquid biopsy based on circulating tumor DNA in non-small cell lung cancer
Frontiersworld

Clinical application of liquid biopsy based on circulating tumor DNA in non-small cell lung cancer

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxNWUJneGt4Z0hKY2hzREVjV2EtYnJjZnZoYUt5d1RKZ2Zka1hpXzYwWGg1Uy1McnkycnRReGxmdGdOVjhvbXJZM3ExTEhhX2NIMDZ4YXEyczZwcXlIeUw2Ml9wajVhTE9pOTl5QnZSblRYb0xCNW9aX1hHWlpXaXdraExTSDROTlVzZDBuN3gtMzJuZw?oc=5" target="_blank">Clinical application of liquid biopsy based on circulating tumor DNA in non-small cell lung cancer</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Use of ctDNA in early breast cancer: analytical validity and clinical potential | npj Breast Cancer
Naturegeneral

Use of ctDNA in early breast cancer: analytical validity and clinical potential | npj Breast Cancer

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE0tOWpGRC0xTFprWW4yY3oxTTg4ODRkWm5QNDZSYUJSaXRTdTRqMHktbkY1TlNOam5PUURYNUt6aTVIZGhhWi1xZFB2VmFnUExkUkhEX0xFRUJWREx3VXln?oc=5" target="_blank">Use of ctDNA in early breast cancer: analytical validity and clinical potential | npj Breast Cancer</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
The Use of Circulating Tumor DNA to Monitor and Predict Response to Treatment in Colorectal Cancer
Frontiersgeneral

The Use of Circulating Tumor DNA to Monitor and Predict Response to Treatment in Colorectal Cancer

<a href="https://news.google.com/rss/articles/CBMijAFBVV95cUxQV18xSnVoYnl2OXpaNENvTWRxWHhreDZod3R5T1FRa0ZWenNxWXV3S1FjMlFXeHpSbjVDWXpWSDFWWW5PTnBtSDlMRU5xUFh5RVFDSVkzWGY3TV9pQ2x6ZmRaWmRDSHVuMzFUdTktVXl0Tk5tN3dadHI5T3pzRUkzckNvTGVaVktLWW05OA?oc=5" target="_blank">The Use of Circulating Tumor DNA to Monitor and Predict Response to Treatment in Colorectal Cancer</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Post-adjuvant chemotherapy in ctDNA-positive patients with resected colorectal cancer: a randomized phase 3 trial
Naturegeneral

Post-adjuvant chemotherapy in ctDNA-positive patients with resected colorectal cancer: a randomized phase 3 trial

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5hR2Rsb3ROU1g5YVJQMWZlQ3BlRzhPbGlsTXVtUjJ5bDZnNmdCcGhHR29WWFYxeTZxaS1zWlJ1dVpSMDZIX3lLOU1OTDg0cm5sa1NnY0RDc1FfS1h3Sk5Z?oc=5" target="_blank">Post-adjuvant chemotherapy in ctDNA-positive patients with resected colorectal cancer: a randomized phase 3 trial</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Molecular response assessment using circulating tumor DNA (ctDNA) in advanced solid tumors
Naturegeneral

Molecular response assessment using circulating tumor DNA (ctDNA) in advanced solid tumors

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE94VUR4SUxEVDh3UFZEX3dHS3NNZVdNRnEtbl9DZzQyVEJzWkZvYmNORjJoT2JvQU1aYktwNU1TM3ZpVkYxcUVlTjhWY3o3U0czTkxRQTNHRndkWjlvTllj?oc=5" target="_blank">Molecular response assessment using circulating tumor DNA (ctDNA) in advanced solid tumors</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Personalized ctDNA micro-panels can monitor and predict clinical outcomes for patients with triple-negative breast cancer
Naturegeneral

Personalized ctDNA micro-panels can monitor and predict clinical outcomes for patients with triple-negative breast cancer

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE90RkIzZXlVZ2dPcmVibVdhUW9YN3BYMXJvSkotbTU4dHFTMnM3LXRhR0IxLW9GbXV1RHg3VWlmeFNScGVDM2dOcng2TVRGeTVxWnRNLV9OT2RBRFAzcU84?oc=5" target="_blank">Personalized ctDNA micro-panels can monitor and predict clinical outcomes for patients with triple-negative breast cancer</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer | British Journal of Cancer
Natureworld

Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer | British Journal of Cancer

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9BZkZtalFwYWFRZk1ZdDFWcmhLX1owX1VBSHVTSTAwWWFVazVsZUs1Q0R2cTVYd05KTDM0UGVyRVlNYk5Ka0tJN1JfQUQ2SExodE54QjU4enJpb19PTUFF?oc=5" target="_blank">Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer | British Journal of Cancer</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancer
Natureworld

Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancer

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9Fb1RmSm56ZW16M2hKVmxyNHctTU9iOU4ySGUxcXZPb3Zpc2g5UW03eFlYVnZES0FmS05MT0VuVW5scU5zQ2haVXkxOGR2UmxscWY4RFFMdWZrNTRqTncw?oc=5" target="_blank">Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancer</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Liquid biopsy could guide treatment decisions for oligometastatic lung cancer
WashU Medicineworld

Liquid biopsy could guide treatment decisions for oligometastatic lung cancer

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxNeWRCZFlnZDV6VERuT3RHTmsxclpxZUwxanNIOUxGalcwTzhHeDN1c18wWTVPR3FjWk13SzlFZVVDYW9QamcwalBpWVNiZnhlX2o4d3hmQ0loVlRWM2QtMDEwb1BDZ0RyQUttel91bmt4a2ZmNVNId3Y3QnBzaTBiX3dGcXkzWEttdDJBOFQ3VmVrN1NhczR0UXE3X1V2N0V2M1J3MlJaaUh2NmdzTXhj?oc=5" target="_blank">Liquid biopsy could guide treatment decisions for oligometastatic lung cancer</a>  <font color="#6f6f6f">WashU Medicine</font>

Read Full StoryMore like this
Future perspectives of uveal melanoma blood based biomarkers
Naturegeneral

Future perspectives of uveal melanoma blood based biomarkers

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1KTDV5cjg4Z2UyVHNaOWFBVHhrT0VWN2ZSc1BJSWIxQlJraFFZSjJUbnROakRTMFFzVEh6dXcwZk9aV01icko0aG1vUUxfUGg3b0tlY2ZuRVBDb2hLMGNN?oc=5" target="_blank">Future perspectives of uveal melanoma blood based biomarkers</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Colorectal Cancer Research From ASCO GI: Immunotherapy, ctDNA, and Surgery
Cancer Therapy Advisorworld

Colorectal Cancer Research From ASCO GI: Immunotherapy, ctDNA, and Surgery

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxQYkUtYXFQajNUN0N4NEpfMEJnUFdSZVNUMHYyUmxhQTBOTDJKT2NQdUg1aDd5TTktNXJ1NlpUeFE4bjdQdkF1NkZ2UnFjY2cteWRQUEtSb09xdjJTeURrY2JfOWtYdTZlQVExbnd4aVYzSDlGSkdqZDgxQ2tSQ3NvQllpMEg4X0xjNG96SWFzb1FIdHdFOW1KX09GQjRxQVRPaGxMU1BMMVRKcmlQ?oc=5" target="_blank">Colorectal Cancer Research From ASCO GI: Immunotherapy, ctDNA, and Surgery</a>  <font color="#6f6f6f">Cancer Therapy Advisor</font>

Read Full StoryMore like this
A Setback for TNBC Monitoring With Circulating Tumor DNA in ZEST Trial
MedPage Todaygeneral

A Setback for TNBC Monitoring With Circulating Tumor DNA in ZEST Trial

<a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTE5Mekd6VWxDbC1OTDBkYTNtVm42UDVYYUJQeTR4ZnVnamxxSWQ3dkRfeUNjMzVjc1FFMk5EbloxQWItZGtlUTVHMWR2MjcxLVZZOXJkVmpoWUJQUXhPODFYMG9yTk9GWk40?oc=5" target="_blank">A Setback for TNBC Monitoring With Circulating Tumor DNA in ZEST Trial</a>  <font color="#6f6f6f">MedPage Today</font>

Read Full StoryMore like this
ctDNA Assay Detects AR Enhancer Alterations Linked to Poor Survival - Russell Pachynski, Aadel Chaudhuri & Christopher Maher
UroTodaygeneral

ctDNA Assay Detects AR Enhancer Alterations Linked to Poor Survival - Russell Pachynski, Aadel Chaudhuri & Christopher Maher

<a href="https://news.google.com/rss/articles/CBMimwJBVV95cUxQVnFYWEJQYnpLN2NDdzlfdW01S0g1VzlTVU1VY2l1dVk3cTFTbjM3dmxFcGtaaURpMDBsRUN5ZWNzbGdtR3RTb0xKOHU5ZFJWdlZBV25vMFJZRmRWR3lRTzVVSHdVeEdaTUcwQk12ZWJGMGF6REdFeVZMNWtLSkNpeWtDaDVjWWN2RWU1UkFTZzNxOUVjYW1RTzk2NlU0RkZyenRZWmQ1ZEZmUXA3Zkd5dFQ2YkJQa1d3OFI3UUJkS3p5UHlQVk15YXVrVXJoUWVUdU55dTlvd3U3NGhYcktMQWFKSmczUVAwMDdfUTVBR2tIY2xnU0EzdTFUZTh4c3Zua1VPWUVWM3RsSGxaTGVfRkJEeUdtSXZOXzhB?oc=5" target="_blank">ctDNA Assay Detects AR Enhancer Alterations Linked to Poor Survival - Russell Pachynski, Aadel Chaudhuri & Christopher Maher</a>  <font color="#6f6f6f">UroToday</font>

Read Full StoryMore like this
Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer
Science | AAASgeneral

Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer

<a href="https://news.google.com/rss/articles/CBMiZ0FVX3lxTFA0OFY2V25RekFlRWw3SlBlWDB5TTZBaUx2Nnpkc1dzdkpsS0dMR1F5YVItV1VNU3lrTFZfcTdsMG1uRnB5cFBsNTlwY0FUQXA1cE9YUDhSWHNlanBESERtSENReHY1MmM?oc=5" target="_blank">Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer</a>  <font color="#6f6f6f">Science | AAAS</font>

Read Full StoryMore like this
New study to develop personalized therapies for triple-negative breast cancer patients
Medical Xpressgeneral

New study to develop personalized therapies for triple-negative breast cancer patients

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxQd3V4YUlGaEQ3R2s5Zlppd0pWQ0xscFExMk95N21OZ0toU29VRzZENHM4dVJjOEhqSVJoZzhEckJkLUZ6V3A2LVlOU2NaTlRmTjVaTzc3bmg2ZTVHellqN1ZDYXZuRkQwU0lyMU16aEpSM0pZQ3VOcG13QUo5eHVSV0wtWXRzdDFWakl6cEdHU2VuR1d3SEd4b3dQV0c?oc=5" target="_blank">New study to develop personalized therapies for triple-negative breast cancer patients</a>  <font color="#6f6f6f">Medical Xpress</font>

Read Full StoryMore like this
‘Revolutionary’ DNA blood test to offer thousands in England tailored cancer care
The Guardiantech

‘Revolutionary’ DNA blood test to offer thousands in England tailored cancer care

<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxPbGxHVEhlN0FrQ2JvVjAxMW9UeGJVcXhib092MmNLbFJnaVJNUzZwc0FfY3BUTW5rUnZjZTdaQlZaX0xNR0NFekwzQnN4VUl1S3FuZDJUNUwwcmJQTHU0Y2RGVzhNa0swWDJsNkxJRkdwVmEzdXB1RzdoZ013Tm1NVEhIN2JNa3RGUV9vNkd6VGZJVjRSN2k1MTd4VC14TUpEemVuVkhPaTVqbnhNd0xxSERFVG9FdDRCdU16VkZyaHV2SW5NWFE?oc=5" target="_blank">‘Revolutionary’ DNA blood test to offer thousands in England tailored cancer care</a>  <font color="#6f6f6f">The Guardian</font>

Read Full StoryMore like this
New method to personalize chemotherapy drug selection
healthcare-in-europe.compolitics

New method to personalize chemotherapy drug selection

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxPSzR3VnBDQXBIbVR1OFR4akQ4d1B6cGxGY2dxdGRWZnIxN0JsWHFfUV9OdmpJSjEwYkEwRncxVGc3SVlBTV93bVQtdWxndDJtNjJqX0xfOHJwcm9nSXpQMHotNUFZQ2F1ZWQwTElNZ0MwQW1paGlYNlNaSEx3eGFQTkFaUXZWSmY4VzNSNnhHcjhSNnY4SXI3MWJUSFFYYzFG?oc=5" target="_blank">New method to personalize chemotherapy drug selection</a>  <font color="#6f6f6f">healthcare-in-europe.com</font>

Read Full StoryMore like this
Guardant Health’s comprehensive liquid biopsy test, Guardant360®, helps guide treatment decisions for pati
The Economic Timesscience

Guardant Health’s comprehensive liquid biopsy test, Guardant360®, helps guide treatment decisions for pati

<a href="https://news.google.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?oc=5" target="_blank">Guardant Health’s comprehensive liquid biopsy test, Guardant360®, helps guide treatment decisions for pati</a>  <font color="#6f6f6f">The Economic Times</font>

Read Full StoryMore like this
"ctDNA Testing May Help Mo" — Live Google News Trends & Headlines